Research Peptides Studied for Muscle & Body Composition
Body composition is one of the most searched areas in peptide research and one of the most oversold. This roundup covers the compounds that actually appear in the research literature for this area, what mechanism each works through, and where each maps to a calculator. It is a reference, not a protocol, and it makes no claims about outcomes.
The GH axis is the common thread
Most compounds discussed in this context act on the growth-hormone axis rather than on muscle directly. They fall into two mechanistic families that are frequently confused: GHRH analogs, which mimic growth-hormone-releasing hormone, and ghrelin-mimetic secretagogues, which act on a different receptor entirely.
That distinction is why the two families are often studied together — they are separate routes to the same axis.
Tesamorelin — GHRH analog
The most clinically studied GHRH analog, approved as a prescription drug for a specific indication. Research-grade material is handled in low milligram amounts and is straightforward to reconstitute. See the Tesamorelin calculator.
CJC-1295 — GHRH analog, with a critical caveat
Appears both with DAC and without it (sometimes labelled Mod GRF 1-29), and the two behave very differently because their half-lives differ by orders of magnitude. The reconstitution maths is identical; how they are studied is not. Confirm which version your vial contains.
Ipamorelin — ghrelin-mimetic secretagogue
A different receptor route from the GHRH analogs, which is why it is so commonly paired with CJC-1295. Handled in micrograms, so draws are small and dilution choice matters for readability. Most commonly supplied as a combined CJC-1295 + Ipamorelin vial — see that blend calculator for per-component maths.
MOTS-c — a different mechanism entirely
A mitochondrial-derived peptide studied for metabolic and mitochondrial-function pathways rather than the GH axis. It appears in body-composition discussion because of that metabolic angle, not because it is a growth-hormone compound. See the MOTS-c calculator.
Recovery compounds are adjacent, not the same
BPC-157 and TB-500 turn up constantly in this conversation because training and recovery are related — but they are studied for tissue repair, not for body composition. Our recovery roundup covers them properly rather than lumping them in here.
What the evidence does and does not support
Worth being blunt: depth of published research varies enormously across this list. Tesamorelin has a substantial clinical record for its approved indication; several others are studied far less, and much of what circulates online extrapolates well beyond what the literature supports. Nothing here is a claim that any compound produces any outcome.
Key takeaways
- Most of these act on the GH axis, not on muscle tissue directly.
- GHRH analogs and ghrelin-mimetic secretagogues are different mechanisms.
- CJC-1295 with vs without DAC are handled very differently — check the label.
- Evidence depth varies enormously; this is a reference, not an endorsement.
